Detalhe da pesquisa
1.
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.
Am J Hematol
; 88(2): 130-4, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23345248
2.
[Decitabine treatment in myelodysplastic syndromes--results of a compassionate patient program in Israel].
Harefuah
; 152(10): 591-4, 624, 2013 Oct.
Artigo
em Hebraico
| MEDLINE | ID: mdl-24450031
3.
Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndrome.
Clin Lymphoma Myeloma Leuk
; 15(6): e95-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819366